Quinchia Jennifer, Echeverri Danilo, Cruz-Pacheco Andrés Felipe, Maldonado María Elena, Orozco Jahir
Max Planck Tandem Group in Nanobioengineering, University of Antioquia, Complejo Ruta N, Calle 67 No. 52-20, Medellín 050010, Colombia.
Grupo Impacto de los Componentes Alimentarios en la Salud, School of Dietetics and Human Nutrition, University of Antioquia, A.A. 1226, Medellín 050010, Colombia.
Micromachines (Basel). 2020 Apr 14;11(4):411. doi: 10.3390/mi11040411.
The accurate determination of specific tumor markers associated with cancer with non-invasive or minimally invasive procedures is the most promising approach to improve the long-term survival of cancer patients and fight against the high incidence and mortality of this disease. Quantification of biomarkers at different stages of the disease can lead to an appropriate and instantaneous therapeutic action. In this context, the determination of biomarkers by electrochemical biosensors is at the forefront of cancer diagnosis research because of their unique features such as their versatility, fast response, accurate quantification, and amenability for multiplexing and miniaturization. In this review, after briefly discussing the relevant aspects and current challenges in the determination of colorectal tumor markers, it will critically summarize the development of electrochemical biosensors to date to this aim, highlighting the enormous potential of these devices to be incorporated into the clinical practice. Finally, it will focus on the remaining challenges and opportunities to bring electrochemical biosensors to the point-of-care testing.
通过非侵入性或微创程序准确测定与癌症相关的特定肿瘤标志物,是提高癌症患者长期生存率、对抗该疾病高发病率和死亡率最具前景的方法。在疾病的不同阶段对生物标志物进行定量分析,可促使采取适当且即时的治疗措施。在此背景下,电化学生物传感器因其具有通用性、响应快速、定量准确以及便于多路复用和小型化等独特特性,在癌症诊断研究中处于前沿地位。在本综述中,在简要讨论结直肠肿瘤标志物测定的相关方面和当前挑战之后,将批判性地总结迄今为止为此目的电化学生物传感器的发展情况,突出这些设备纳入临床实践的巨大潜力。最后,将聚焦于将电化学生物传感器应用于即时检测所面临的剩余挑战和机遇。